Clinical Trial Update: Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes with Suppressive Capacity in MS

View source ↗

Summary

A clinical trial investigates the effect of ocrelizumab on peripheral lymphocyte immunophenotypes and their suppressive capacity. The study targets individuals …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Dr Recai Turkoglu | Conditions: Multiple Sclerosis | Status: ACTIVE_NOT_RECRUITING